News
AstraZeneca PLC AZN has struck a deal to buy a portfolio of gene therapies from Pfizer Inc. PFE for up to $1 billion, the biopharma company announced Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback